Objective: This study explored whether the increased extracellular relative to intracellular fluid (ECF/ICF) ratio in obesity might reflect osmotic effects of elevated plasma solute concentrations. Design: Cross-sectional, epidemiological survey. Setting and subjects: The present analysis used nationally representative data from the Third National Health and Nutrition Examination Survey on community-dwelling adults (aged 40-59 years) in the US without evidence of glucose dysregulation or chronic disease (n ¼ 1285). Intervention: Body mass index (BMI) was estimated from measured height and weight. Total body reactance, an index of body fluid distribution, was determined by bioelectrical impedance analysis. Plasma tonicity (the cumulative index of osmotically effective plasma solute) was estimated from plasma glucose, sodium and potassium. Sex-specific relative odds of lower reactance (p50 O/m for women, p40 O/m for men) and plasma hypertonicity (tonicity X295 mmol/l) associated with overweight (25pBMI o30) and obesity (BMIX30) were estimated using logistic regression models that controlled for sociodemographic variables, smoking, leisure-time physical activity, total energy intake, serum creatinine, plasma insulin and glucose. Multinomial logistic regression models tested for associations between weight status and specific serum solute. Results: Independent of covariates, in men and women, overweight and obesity were associated with increased odds of lower reactance and hypertonicity. Overweight and obese individuals with lower reactance had significantly higher serum sodium than normal weight individuals. Conclusions: Elevated plasma solute concentrations are associated with obesity in free-living adults. Physicians and researchers should be alert to a possible link between hypertonicity and obesity.
Introduction
Obesity is characterized by an altered distribution of body fluid. Overweight and obese individuals have a greater volume of extracellular relative to intracellular fluid (ECF/ ICF) compared to normal weight persons Raison et al., 1986; Waki et al., 1991; Steijaert et al., 1997; Van Marken Lichtenbelt and Fogelholm, 1999; Mingrone et al., 2001; DeLorenzo et al., 2003) . More particularly, the altered fluid distribution is associated with abdominal obesity, the obesity phenotype most strongly associated with male sex, peri-menopausal obesity in women, and the metabolic syndrome, 'Syndrome X' (Raison et al., 1992; Zamboni et al., 1992; Bjorntorp, 1996; Bosello and Zamboni, 2000; Paccaud et al., 2000; Cikim et al., 2004) .
Several mechanisms have been proposed to explain the excess ECF/ICF volume observed with obesity. The phenomenon may reflect overhydration, excess total body water, related to disordered fluid regulation, edema, hormones secreted by adipose tissue, a higher ECF/ICF ratio of adipose tissue, atrophied tissues or malnutrition Waki et al., 1991; Van Marken Lichtenbelt and Fogelholm, 1999; Leone et al., 2000; Pasquali and Vicennati, 2000; Vicennati and Pasquali, 2000) . The excess extracellular volume might alternatively reflect cell dehydration, normal fluid shifts out of cells to the extracellular space in response to osmotic stress from plasma solute (Van Marken Lichtenbelt and Fogelholm, 1999) . It is well known that the extracellular volume is maintained at the expense of the intracellular space (Lavizzo-Mourey, 1987) .
As plasma hypertonicity, elevated plasma concentrations of osmotically effective solute, is prevalent in US adults (Stookey, 2005; Stookey et al., 2005) , the altered fluid distribution in obesity may reflect hypertonic cell shrinkage. A relationship between obesity and hypertonicity is plausible, because both conditions have similar risk factors and adverse consequences. Low intake of water relative to solute (low vs high water foods and caloric beverages vs plain water) is associated with overeating (Rodin, 1990; Rolls et al., 1990; Rolls et al., 1999; Stookey, 2001; Almiron-Roig and Drewnowski, 2003) and hypertonicity (Pedersen et al., 2001; Shirreffs et al., 2004) . Obesity and hypertonicity are associated with metabolic dysregulation, increased protein breakdown and glucose intolerance, decreased lipolysis, and negative outcomes including impaired physical performance, increased risk of incident diabetes and disability (Bratusch-Marrain and DeFronzo, 1983; Sawka, 1992; Berneis et al., 1999; Keller et al., 2003; Stookey et al., 2004a, b) . Like obesity, hypertonicity is both cause and consequence of glucose dysregulation (Waldhausl et al., 1979; Wolfe et al., 1979; Bratusch-Marrain and DeFronzo, 1983; Burg and Kador, 1988; Komjati et al., 1989; Echegaray et al., 2001) .
It is important to understand why obesity is associated with a greater ECF/ICF volume. Although the altered fluid distribution is already recognized as a complication of abdominal obesity and source of error in body composition assessment, greater understanding about this association might shed light on the etiology of obesity. Relative overhydration vs cell dehydration, and abnormal fluid regulation vs normal adaptation to hyperosmotic stress could have different implications for obesity prevention and treatment.
To explore hypertonicity as a possible explanation for the altered fluid distribution in obesity, this study tested for associations between overweight and obese status, lower body bioelectrical impedance (BIA) reactance, and plasma hypertonicity in a population-based sample of non-acutely ill, free-living middle-aged adults. Lower BIA reactance is an indicator of altered body fluid distribution, lower body cell mass and intracellular fluid (Liedtke, 1998; DeLorenzo et al., 2000; Buffa et al., 2003; Mika et al., 2004; Bosy-Westphal et al., 2005) . Considering that glucose intolerance is a known cause of hypertonicity and known correlate of obesity, glucose intolerance could confound or explain associations between hypertonicity and obesity. To facilitate inferences about plasma hypertonicity (a cumulative index of all osmotically effective solute) as opposed to hyperglycemia (elevated concentrations of glucose only), the study sample was restricted to individuals without evidence of glucose dysregulation. The analysis also controlled for plasma glucose level using multivariable statistical models, and tested for associations between obesity and elevated plasma concentrations of solute other than glucose. To account for differing obesity phenotypes by age and sex, the analysis was gender stratified and focused on a narrow age group, including perimenopausal women.
Methods

Sample
Data from the Third National Health and Nutrition Examination Survey (NHANES III) were used for this analysis (US-DHHS, 1997). NHANES III was a nationally representative, cross-sectional survey conducted by the National Center for Health Statistics (NCHS) between 1988 and 1994. Noninstitutionalized civilian men and women, aged 2 months and older, were sampled using a stratified, multistage probability cluster design, with oversampling for Mexican Americans, African Americans, and the elderly. The survey included a household interview, as well as a visit to a mobile examination center (MEC) for dietary assessment, physical examination and laboratory tests. Details about the recruitment and data collection protocols have been published previously (US-DHHS, 1994) . The survey procedures were approved by the NCHS Internal Review Board, and all participants gave informed consent.
The present analysis focused on data from non-Hispanic white, non-Hispanic black and Mexican American adults aged 40-59 year who were not pregnant, with no previous diagnosis of high blood pressure, heart attack, stroke, or cancer, and no evidence of kidney dysfunction (serum creatinine 41.5 mg/dl or serum blood urea nitrogen 420 mg/dl). Considering that hypertonic dehydration is a well-known consequence of glucose intolerant states (Star, 1990) , individuals with evidence of insulin resistance, glucose intolerance or diabetes were excluded from the study sample to avoid potential confounding of the association of interest by glucose intolerance. The specific exclusion criteria for glucose dysregulation were: a fasting insulin of 20 mU/ml or greater (Carnethon et al., 2003) , a fasting glucose of 110 mg/dl or greater, a non-fasting glucose or 2-h post-oral glucose tolerance test (OGTT) glucose of 140 mg/dl or greater (ECDCDM, 2003) , self-reported current use of insulin or previous diagnosis of diabetes. The final study sample (n ¼ 1285) excluded 18 people who were underweight body mass index (BMIo18.5), 12 people with abnormally low plasma tonicity (o285 mmol/l), and 77 people with missing BIA data.
Anthropometric status
Body weight, height, waist and buttocks circumference were recorded following standardized protocol during the MEC examination (US-DHHS, 1994 (Kuczmarski and Flegal, 2000) . For sample descriptive purposes, the waist:hip ratio was calculated from the waist and buttock circumferences, and classified with respect to 0.85, a cutoff associated with increased health risk (Paccaud et al., 2000; Cikim et al., 2004) .
Bioelectrical impedance
During the MEC examination, a board-eligible physician collected whole BIA measurements using a single frequency (50 kHz) Valhalla Scientific Body Composition Analyzer 1990B. Survey participants were measured in a supine position, with electrodes attached to the right wrist, hand, ankle and foot (US-DHHS, 1996f). Bioimpedance analysis was not done on individuals with amputations other than fingers or toes. The reactance parameter represents the capacitive impedance of cell membranes, that is, the ability of body cells to store an electrical charge (Liedtke, 1998) .
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Total body reactance indexes body cell mass and intracellular volume (Liedtke, 1998; DeLorenzo et al., 2000) without need for the assumptions that would be necessary to calculate fluid volume (Piccoli et al., 1998) . BIA reactance was expressed relative to height (O/m) in order to control for different conductor (body) length (Dumler and Kilates, 2003) . The continuous reactance variable was collapsed to a dichotomous variable using sex-specific cutoffs that approximate the mean reactance in normal weight men (40 O/m) and normal weight women (50 O/m) in this sample.
Blood collection and laboratory methods
During the MEC examination, trained staff collected a blood sample from individuals who reported no hemophilia or recent cancer chemotherapy. A second blood sample was drawn for a standard 2-h OGTT. Detailed specimen collection and processing instructions are described in several manuals (DHHS, 1996a-d) . Serum and plasma were separated from the specimens within 1 h of collection, transported on dry ice to the participating laboratories, and stored refrigerated or frozen, as appropriate, until analysis. Assays for serum sodium, potassium, and creatinine were carried out by the White Sands Clinical Laboratory (Alamogordo, NM, USA). Plasma glucose and insulin were assayed at the University of Missouri-Columbia School of Medicine, Department of Child Health, Diabetes Reference Laboratory (Columbia, MO, USA). The continuous plasma glucose variable was collapsed to a dichotomous indicator using the upper-limit for a normal fasting glucose (100 mg/dl). The continuous serum sodium and potassium variables were collapsed to dichotomous indicator variables using approximate mean values for the men and women in this sample: (4 mmol/l potassium, 141 mmol/l sodium).
Plasma tonicity
Plasma tonicity (mmol/l) was estimated from plasma glucose, serum sodium and potassium, as in previous analyses (Matz, 1996; Stookey et al., 2004a Stookey et al., , b, 2005 :
, with sodium and potassium in (mmol/l) units and glucose in (mg/dl) units. The normal range (285-295 mmol/l) suggested by Matz (1996) was used to classify participants with respect to normal vs elevated plasma tonicity. Values above 295 mmol/l are associated with hemoconcentration, biologically meaningful differences in bioelectrical impedance and disease status (Stookey et al., 2004a (Stookey et al., , b, 2005 .
Behavioral covariates
In addition to socio-demographic information, data were collected about current smoking status (yes/no), and leisuretime physical activity. The physical activity data were collapsed using frequency and intensity criteria (Ainsworth et al., 1993; Pate et al., 1995; King et al., 2001) , to reflect never (0 times/week), infrequent (1-4 times/week) and frequent (X4 times/week) participation in moderate or vigorous leisure activities (jogging, swimming, aerobics, calisthenics, bike riding, dancing, gardening and weight lifting (activities with X3 metabolic equivalents -METs)).
Energy intake
During the MEC examination, a trained dietary interviewer conducted a 24-h dietary recall, using an automated, microcomputer-based interview and coding system (US-DHHS, 1994; US-DHHS, 1996e). Recall aids, including food models, special charts and measuring cups, were used to help individuals recall the types and amounts of foods and beverages consumed for the previous 24 h period. Special probes were used to help participants remember condiments, accompaniments, fast foods and beverages. The recall interviews were reviewed, edited and coded for completeness and reliability. The recall information deemed reliable and complete was converted into estimates of total energy intake using the NHANES III nutrient database for individual foods (NCHS, 1997). Energy intake was evaluated in absolute (kcal) and relative terms (kcal/kg body weight). According to Liedtke (1998) , the BIA electrical signal leaks through protein channels in the cell membrane and charges the inside of the cells lipid bilayer. As the same charge with opposite polarity exists on the outside of the cell bilayer, the cell membrane acts as a capacitor that can store a charge of electrons for a period of time. Capacitors give circuits reactance and cause electrical current to lag. The amount of charge a capacitor will hold is proportional to the area of the charged membrane.
Statistical analyses
All analyses were conducted using Stata SE 8.0 (Stata Corp, 2003) . Sex-specific logistic regression models were used to estimate the relative odds of lower reactance (Xc) associated with overweight and obese status. Sex-specific logistic regression models were next used to estimate the relative odds of elevated plasma tonicity associated with overweight and obese status. Further logistic regression models were used to estimate the relative odds of hypertonicity for overweight and obese individuals with evidence of an altered fluid distribution (lower reactance) compared to normal weight individuals with no evidence of altered fluid distribution (higher reactance). Indicator variables defined four weight status sub-groups in these models: BMIo25 & Higher Xc, BMIo25 & Lower Xc, BMIX25 & Higher Xc, BMIX25 & Lower Xc. All models adjusted for age, race/ ethnicity, current smoking, leisure activity, total energy intake (kcal), serum creatinine (an index of renal function) and plasma insulin. Energy intake was evaluated in all models in absolute (kcal) and relative terms (kcal/kg). As both specifications produced the same results, results from models controlling for absolute energy intake are presented. All standard errors were computed using a robust variance estimator (using the cluster command available in Stata) to account for survey design effects.
To evaluate whether observed associations between weight status and hypertonicity might be attributable to glucose, additional models controlled for plasma glucose. Serum sodium, potassium and glucose were entered into sexspecific multinomial logistic regression models predicting weight status to test for independent associations between serum sodium and/or potassium and overweight status, controlling for plasma glucose and all other covariates. Table 1 describes the sample characteristics. The prevalence of overweight and obesity in men and women was 45.6 and 13.6%, and 33.2 and 23.2%, respectively. In both sexes, elevated weight status was associated with recognized risk factors, non-Hispanic Black and Mexican American race/ ethnicity, low level of physical activity, and non-smoking status. All (99.7%) overweight men had a waist:hip ratio of 0.85 or greater. Two-thirds (69.1%) of overweight women had a waist:hip ratio of 0.85 or greater. In this sample of individuals without evidence of diabetes, glucose intolerance or insulin resistance, overweight and obesity were associated with significantly higher plasma insulin levels, but not higher energy intake, serum creatinine or plasma glucose levels.
Results
The bottom of Table 1 presents mean serum chemistry values by sex and weight status. Although the mean serum electrolyte and plasma glucose values were within the respective normal ranges for all weight status groups, when the values were combined to reflect plasma tonicity, the mean values for tonicity for all groups were above normal. In men the prevalence of hypertonicity was 67.2%. In women the prevalence was 55.5%. Obese men and women had significantly lower mean reactance than normal weight men and women. Table 2 presents the relative odds of a below average reactance associated with overweight and obesity. Overweight men and women were over twofold more likely to have a lower reactance than their normal weight counterparts. Obese individuals of both sexes were over seven times more likely to have a below average reactance. Table 3 presents the relative odds of plasma hypertonicity associated with overweight and obese status in men and women. Controlling for all covariates, overweight men were 50% more likely to have hypertonic plasma than their normal weight counterparts. Obese men were twice as likely to have hypertonic plasma than normal weight men. Obese women were over 50% more likely to have hypertonic plasma than normal weight women. Statistical control for plasma glucose did not change the observed magnitudes of association. Figure 1 illustrates the bivariate relationship between reactance and plasma tonicity by weight status. As overweight status was negatively associated with reactance and positively associated with plasma tonicity, the bivariate distribution shifted down and to the right with overweight and obesity.
The bottom of Table 3 presents the relative odds of plasma hypertonicity for overweight or obese individuals who had a below average reactance. Compared to normal weight individuals with an above average reactance, obesity with lower reactance was associated with significantly greater odds of plasma hypertonicity. This pattern of results was observed for both sexes. Statistical control for plasma glucose did not change the observed magnitudes of association.
Plasma glucose did not account for all of the variation in plasma tonicity. At each level of plasma glucose, tonicity varied with other solute concentrations. In both sexes, plasma tonicity was strongly correlated with serum sodium (r40.9, P-value o0.001) and weakly correlated with serum potassium (ro0.3, Po0.001) and plasma glucose (ro0.2, P-valueo0.001). Of the hypertonic men, 96% had a serum sodium above 141 mmol/l, 23% had a plasma glucose above 100 mg/dl, and 66% had a serum potassium above 4 mmol/l. Of the hypertonic women, 95% had a serum sodium over 141 mmol/l, 16% had a plasma glucose above 100 mg/dl and 61% had a potassium over 4 mmol/l.
Multinomial logistic regression models were fitted with weight status as dependent variable and the determinants of plasma tonicity (sodium, potassium and glucose) as independent variables. In these models (Table 4) , serum sodium was associated with significantly increased odds of obesity in men and women, independent of glucose. Overweight or obese men with a below average reactance were 70% more likely to have a serum sodium over 141 mmol/l than normal weight men with an above average reactance. Similarly, Significantly different likelihood of overweight or obesity (P-value o0.05 in unadjusted multinomial or logistic regression models) compared to the corresponding reference category (men, youngest age, white race/ethnicity, lowest frequency of leisure activity, non-smoker or waist:hip ratio o0.85). Significantly different mean compared to the normal weight group (P-valueo0.05 in unadjusted regression models). Normal ranges for serum sodium: 135-146 mmol/l, serum potassium: 3.5-5.3 mmol/l and fasting glucose: 65-99 mg/dl.
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overweight or obese women with a below average reactance were 40% more likely to have a higher serum sodium than normal weight women with an above average reactance.
Discussion
The results of this study suggest that the greater ECF/ICF ratio characteristic of obesity may reflect hypertonic stress on cells. In this study sample, overweight and obesity were associated with lower BIA reactance, an index of lower body cell mass and intracellular volume. Overweight and obese individuals with lower reactance were significantly more likely to have hypertonic plasma than normal weight individuals. The observed associations were independent of recognized socio-demographic health and behavioral risk factors for obesity. The results imply that the greater ECF/ICF ratio characteristic of obesity may reflect osmotic fluid shifts out of cells as opposed to overhydration. Plasma hypertonicity, excess plasma concentrations of osmotically effective solute, was prevalent in this sample of non-acutely ill, free-living individuals, affecting approximately 60% of participants. Plasma hypotonicity, a clinical indicator of excess extracellular water, was comparatively rare. Less than 2% of participants in the NHANES III survey aged 40-59 year without chronic disease or glucose dysregulation had a plasma tonicity below 285 mmol/l.
Overweight and obese individuals in this sample were significantly more likely to be hypertonic than their normal OR and 95% CI were estimated using sex-specific logistic regression models predicting lower vs higher reactance that controlled for age, race/ethnicity, leisure activity, current smoking, total energy intake, plasma insulin and serum creatinine. b P-value o0.05 for comparison with normal weight group. 
OR ( Abbreviations: BMI, body mass index; CI, confidence intervals; OD, odds ratio.
Elevated tonicity:X295 mmol/l; normal weight: 18.5pBMIo25; overweight: 25pBMIo30; obese: BMIX30; lower reactance (Xc) for women:p50 ohm/m; lower reactance for men:p40 ohm/m. a OR and 95% CI were estimated using sex-specific logistic regression models predicting normal vs elevated tonicity that controlled for age, race/ethnicity, leisure activity, current smoking, total energy intake, plasma insulin and serum creatinine. Plasma glucose was added to the multivariable models. weight counterparts, independent of plasma glucose level. Although elevated plasma glucose concentrations (a cause of hypertonicity Star, 1990) , might explain an association between hypertonicity and obesity, glucose concentrations alone do not account for the associations observed in this study. Overweight and obese individuals had higher serum sodium concentrations than normal weight individuals for a given plasma glucose level. The higher serum sodium in the overweight and obese group is noteworthy, because the sodium concentration is normally regulated to prevent increases in tonicity. For each 5.5 mmol/l increase in glucose above the normal glucose concentration, for example, serum sodium normally drops by approximately 1.5 mmol/l (Halperin and Goldstein, 1999) . It is presently unknown why obesity is associated with a greater ECF/ICF ratio, nor whether the phenomenon represents a cause or consequence of obesity. If attributable to hypertonicity, the altered fluid distribution in obesity could be more than a correlate of obesity or source of error in body composition assessment. The altered fluid distribution could play an important role in the development of obesity and/or its consequences. In healthy young men, Figure 1 Bivariate relationships between plasma tonicity and reactance by weight status in men and women. Plasma tonicity (mmol/l) was calculated as: [2 Â (sodium þ potassium)] þ [(glucose)/18], with sodium and potassium in mmol/l units and glucose in mg/dl units. The normal range for plasma tonicity is 285-295 mmol/l (Matz, 1996) . The cutoffs for reactance of 40 O/m for men and 50 O/m for women approximate the average reactance values observed for normal weight men and women in this sample.
Altered fluid distribution in obesity JD Stookey et al hypertonicity increases whole-body protein breakdown, gluconeogenesis and insulin resistance, and decreases glucose uptake, lipolysis and energy expenditure (Bratusch-Marrain and DeFronzo, 1983; Berneis et al., 1999; Boschmann et al., 2003; Keller et al., 2003) . Hypertonic stress causes oxidative stress and DNA damage in the kidney in vitro and in vivo (Dmitrieva and Burg, 2005) . Over time, hypertonicity might promote weight gain and loss of lean mass (sarcopenic obesity) by decreasing lipolysis and energy expenditure. By increasing insulin resistance and oxidative stress, hypertonicity might promote metabolic disorders related to obesity, including diabetes and renal disease. Appropriate treatments for obesity may depend on the cause of the altered fluid distribution. If owing to hypertonicity, treatments to remove apparent excess body water (e.g. loop diuretics (furosemide) might do harm by aggravating hypertonic stress on cells.
Awareness about hypertonicity as a possible risk factor for and/or consequence of obesity might inform prevention or treatment strategies. Hypertonicity may reflect any disorder resulting in loss of body water, decreased fluid intake or the addition of solute to the extracellular space (Star, 1990) . Cellular (e.g. abnormal Na/K pump activity) and physiologic (hormonal regulation of fluid and electrolyte balance) abnormalities, and low fluid relative to solute intake can cause plasma hypertonicity. Depending on the cause of hypertonicity, interventions to lower plasma tonicity by decreasing body water loss, increasing water intake, and/or decreasing extracellular solute concentrations via diet, activity or medications might be indicated.
Physicians and researchers may not be alert to hypertonicity in non-acutely ill overweight groups. Overweight individuals with altered fluid distribution may have normal blood chemistry values (Leone et al., 2000) . As plasma hypertonicity was prevalent in this study population, despite normal blood chemistry values, it may be important to evaluate the combined effects of plasma solute.
Further work is needed to pursue hypertonicity as an explanation for the increased ECF/ICF ratio in obesity. The present study did not measure the ECF/ICF distribution directly. The present study may also underestimate the relationship between obesity and plasma hypertonicity in free-living individuals, because individuals with evidence of glucose dysregulation were excluded from the study sample. Abbreviations: BMI, body mass index; CI, confidence intervals; OD, odds ratio. Normal weight: 18.5pBMIo25; overweight: 25pBMIo30; obese: BMIX30; lower reactance (Xc) for women:p50 ohm/m; lower reactance (Xc) for men: p40 ohm/m. 1 OR and 95% CI were estimated using sex-specific multinomial logistic regression models predicting weight status (BMI only or BMI stratified by reactance level) that controlled for age, race/ethnicity, leisure physical activity, current smoking, total energy intake, plasma insulin and serum creatinine. a P-value o0.05 for comparison with corresponding reference group (normal weight or normal weight with higher Xc). The cutoffs of 141 mmol/l for sodium and 4 mmol/l for potassium represent approximate mean values for the men and women in this sample, respectively. The upper bound for a normal fasting plasma glucose is 100 mg/dl.
